Works matching IS 1471-2407 AND VI 14 AND IP 1 AND DT 2014

Results: 1640
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-991
    By:
    • Chaari, Mourad;
    • Ayadi, Ines;
    • Rousseau, Aurelie;
    • Lefkou, Elmina;
    • Vandreden, Patrick;
    • Sidibe, Fatoumata;
    • Ketatni, Hela;
    • Galea, Vassiliki;
    • Khaterchi, Amir;
    • Bouzguenda, Racem;
    • Frikha, Mounir;
    • Ghorbal, Lilia;
    • Daoud, Jamel;
    • Kallel, Choumous;
    • Quinn, Martin;
    • Gligorov, Joseph;
    • Lotz, Jean Pierre;
    • Hatmi, Mohamed;
    • Elalamy, Ismail;
    • Gerotziafas, Grigoris T.
    Publication type:
    Article
    13

    Serum glucose and risk of cancer: a meta-analysis.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-985
    By:
    • Crawley, Danielle J.;
    • Holmberg, Lars;
    • Melvin, Jennifer C.;
    • Loda, Massimo;
    • Chowdhury, Simon;
    • Rudman, Sarah M.;
    • Van Hemelrijck, Mieke
    Publication type:
    Article
    14
    15
    16

    Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-982
    By:
    • Tone, Alicia A.;
    • McConechy, Melissa K.;
    • Yang, Winnie;
    • Jiarui Ding;
    • Yip, Stephen;
    • Kong, Esther;
    • Kwong-Kwok Wong;
    • Gershenson, David M.;
    • Mackay, Helen;
    • Shah, Sohrab;
    • Gilks, Blake;
    • Tinker, Anna V.;
    • Clarke, Blaise;
    • McAlpine, Jessica N.;
    • Huntsman, David
    Publication type:
    Article
    17

    Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-981
    By:
    • Lamm, Wolfgang;
    • Natter, Camilla;
    • Schur, Sophie;
    • Köstler, Wolfgang J.;
    • Reinthaller, Alexander;
    • Krainer, Michael;
    • Grimm, Christoph;
    • Horvath, Reinhard;
    • Amann, Gabriele;
    • Funovics, Philipp;
    • Brodowicz, Thomas;
    • Polterauer, Stephan
    Publication type:
    Article
    18

    Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-980
    By:
    • Ciacio, Oriana;
    • Voron, Thibault;
    • Pittau, Gabriella;
    • Lewin, Maité;
    • Vibert, Eric;
    • Adam, René;
    • Cunha, Antonio Sa;
    • Cherqui, Daniel;
    • Schielke, Astrid;
    • Soubrane, Olivier;
    • Scatton, Olivier;
    • Salloum, Chady;
    • Azoulay, Daniel;
    • Goyer, Perrine;
    • Vaillant, Jean-Christophe;
    • Hannoun, Laurent;
    • Boleslawski, Emmanuel;
    • Agostini, Hélène;
    • Samuel, Didier;
    • Castaing, Denis
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-973
    By:
    • Ness, Andrew Robert;
    • Waylen, Andrea;
    • Hurley, Katrina;
    • Jeffreys, Mona;
    • Penfold, Chris;
    • Pring, Miranda;
    • Leary, Sam;
    • Allmark, Christine;
    • Toms, Stu;
    • Ring, Susan;
    • Peters, Tim J.;
    • Hollingworth, Will;
    • Worthington, Helen;
    • Nutting, Chris;
    • Fisher, Sheila;
    • Rogers, Simon N.;
    • Thomas, Steven J.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33

    DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-965
    By:
    • Martinez-Useros, Javier;
    • Rodriguez-Remirez, Maria;
    • Borrero-Palacios, Aurea;
    • Moreno, Irene;
    • Cebrian, Arancha;
    • Gomez del Pulgar, Teresa;
    • del Puerto-Nevado, Laura;
    • Vega-Bravo, Ricardo;
    • Puime-Otin, Alberto;
    • Perez, Nuria;
    • Zazo, Sandra;
    • Senin, Clara;
    • Fernandez-Aceñero, Maria J.;
    • Soengas, Maria S.;
    • Rojo, Federico;
    • Garcia-Foncillas, Jesus
    Publication type:
    Article
    34
    35

    ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-963
    By:
    • Tota, Giuseppina;
    • Coccaro, Nicoletta;
    • Zagaria, Antonella;
    • Anelli, Luisa;
    • Casieri, Paola;
    • Cellamare, Angelo;
    • Minervini, Angela;
    • Minervini, Crescenzio Francesco;
    • Brunetti, Claudia;
    • Impera, Luciana;
    • Carluccio, Paola;
    • Cumbo, Cosimo;
    • Specchia, Giorgina;
    • Albano, Francesco
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin--gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-953
    By:
    • Borget, Isabelle;
    • Pérol, Maurice;
    • Pérol, David;
    • Lavolé, Armelle;
    • Greillier, Laurent;
    • Dô, Pascal;
    • Westeel, Virginie;
    • Crequit, Jacky;
    • Poudenx, Michel;
    • Vaylet, Fabien;
    • Chabaud, Sylvie;
    • Vergnenegre, Alain;
    • Zalcman, Gérard;
    • Chouaïd, Christos
    Publication type:
    Article
    46
    47
    48
    49
    50